drugset / Trial / NCT03620890
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine whether use of detemir compared to neutral protamine hagedorn (NPH) decreases rates of composite neonatal outcome and maternal hypoglycemia events in women with Type 2 Diabetes Mellitus (T2DM).
Timeline
- Start
- 2018-09-04
- Primary completion
- 2020-07-29
- Completion
- 2020-07-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Neutral Protamine Hagedorn | Unknown | — | Other |
| Comparator | insulin detemir | Protein / enzyme biologic | — | — |